VIVOLIGHT_MEDICAL

We’re heading to TCT 2025! 🚀

From October 25–28 in the USA,Vivolight will showcase our latest cardiovascular OCT imaging system at TCT 2025.

✨ Don’t miss the chance to:
✔️ Experience our advanced OCT technology live
✔️ Learn how it empowers interventional cardiology
✔️ Connect with our expert team

📍 Visit us at Booth【1929】

We can’t wait to meet you at #TCT2025! Let’s shape the future of cardiovascular imaging together. 💙

Visit us！！
Email：sales@vivo-light.com
Web: www.vivolight.com

3 months ago | [YT] | 1

VIVOLIGHT_MEDICAL

ESC Chinese Voice | Professor Chen Yundai's Research Team: Plaque Attenuation Index for Quantitative Description of Atherosclerotic Plaques in Imaging-Pathology Correlative Study

On September 1st, Professor Zhou Shanshan from the Chinese People's Liberation Army General Hospital, introduced the quantitative index derived from optical coherence tomography (OCT), the Plaque Attenuation Index (IPA), at the Late-Breaking Science session of the ESC 2024 conference, for the quantitative characterization of atherosclerotic plaques by OCT imaging.


Study Background and Purpose: Atherosclerosis, as a dynamically evolving pathological process, assessing its pathological types is crucial for judging the risk level of plaques. Previous scholars have meticulously classified atherosclerotic plaques based on autopsy results, with fibrous plaques, fibrocalcific plaques, and fibro-lipid plaques being considered of high clinical significance. Inflammation, especially macrophages, plays an important role in the occurrence and development of atherosclerotic plaques. OCT, with its high axial resolution, excels in detection of the microstructure of plaques, including macrophages. However, the accurate interpretation of OCT images largely depends on the physician's own experience, and the ability for quantitative assessment is very limited.


IPA, based on OCT attenuation imaging, visually reflects the optical attenuation characteristics of each OCT cross-section in a graphical form and calculates the corresponding attenuation values using a special algorithm. It can reflect subtle tissue structure changes that are not easily detected by traditional clinical imaging methods and has great potential in quantitatively describing plaque composition and assessing plaque stability. This study comprehensively describes the attenuation characteristics of atherosclerotic plaques through precise matching of autopsy cardiac specimens' attenuation imaging and pathology, and further explores the potential role of macrophages in IPA plaque classification.

Study result reveals that there are obvious differences in attenuation imaging among different pathological types of plaques, and the IPA value has excellent discriminative performance for significant plaques with high clinical value. At the same time, the study also observed the key role of macrophages in the performance of IPA. Researchers have indicated that IPA can objectively interpret OCT images, provide quantitative data, and help doctors assess atherosclerotic plaques more quickly, accurately, and consistently. Using IPA for clinical tracking of plaque types can dynamically understand the progression of plaques, providing an objective tool for assessing the efficacy of new drugs, new technologies, and new strategies. Its broader clinical application value still requires further exploration and validation in subsequent clinical trials.

Skip the Carousel

1 2 3 4 5

1 year ago | [YT] | 0

VIVOLIGHT_MEDICAL

Step into the future of healthcare with us at the Hospitalar Fair! ⚡️

1 year ago | [YT] | 1

VIVOLIGHT_MEDICAL

🌟 Celebrating International Nurses Day 🌟

Today, we honor the heart and soul of healthcare—our nurses! Your dedication, compassion, and courage inspire us every day. Thank you for your unwavering care and for being our everyday heroes. 💉💙
#InternationalNursesDay #HealthcareHeroes #ThankYouNurses

1 year ago | [YT] | 0

VIVOLIGHT_MEDICAL

🎈The 1st overseas OCT academic program, VivoAcademy, was successfully held by Vivolight Medical.
Its aim was to facilitate an exchange of experiences with overseas clinical experts to enhance their OCT skills. The program lasted nearly two weeks, and included the Hong Kong CICF, academic lectures, and a tour of Vivolight's headquarters.
Participants engaged in extensive communication about their OCT experiences, which helped them refine their intravascular intervention skills and deal with a variety of troubleshooting scenarios.
All participants expressed a strong interest in promoting further exchange events to advance academic excellence and improve clinical practices.

Skip the Carousel

1 2 3 4

1 year ago | [YT] | 1